Net loss per share (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share

The following common stock equivalents were excluded from the calculation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect (in thousands):

	For the three months ended March 31,
	2024
Outstanding stock options(1)	7,903
Restricted stock units(1)	5,449
Warrants	2,586
ESPP shares and other	84
	16,022

(1) Outstanding stock options and restricted stock units include awards outstanding to employees of 2seventy bio.